| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-08 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-05 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |